Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
ACS Central Science|December 8, 2016
Homogenous Electrocatalytic Oxygen Reduction Rates Correlate with Reaction Overpotential in Acidic Organic SolutionsMichael L Pegis, Bradley A McKeown, Neeraj Kumar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 19, 2024
The Utility of Coronary Revascularization to Reduce Ventricular Arrhythmias in Coronary Artery Disease Patients: A Systematic ReviewJoey Junarta, Muhammad U Siddiqui, Ehab Abaza, et al.
Chem|April 19, 2021
Metalloradical activation of carbonyl azides for enantioselective radical aziridinationXavier Riart-Ferrer, Peng Sang, Jingran Tao, et al.
AEM Education and Training|November 5, 2020
Converting to Connect: A Rapid RE-AIM Evaluation of the Digital Conversion of a Clerkship Curriculum in the Age of COVID-19Alim Nagji, Yusuf Yilmaz, Peter Zhang, et al.
Human Molecular Genetics|June 7, 2013
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model miceErica D Koval, Carey Shaner, Peter Zhang, et al.
Circulation. Cardiovascular Interventions|July 12, 2024
Composite Pulmonary Embolism Shock Score and Risk of Adverse Outcomes in Patients With Pulmonary EmbolismRobert S Zhang, Eugene Yuriditsky, Peter Zhang, et al.
Plastic and Reconstructive Surgery|March 27, 2015
Classification of mandible defects and algorithm for microvascular reconstructionBenjamin D Schultz, Michael Sosin, Arthur Nam, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 14, 2010
Photocurrent generation from porphyrin/fullerene complexes assembled in a tethered lipid bilayerWei Zhan, Kai Jiang, Matthew D Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitorJinsong Li, Hongzhang Huang, Lijuan Sun, et al.
The Journal of Clinical Psychiatry|August 25, 2015
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind studyMichael E Thase, James M Youakim, Aleksandar Skuban, et al.
Pageof 17